Search Orphan Drug Designations and Approvals
-
Generic Name: | Talabostat |
---|---|
Date Designated: | 01/26/2021 |
Orphan Designation: | Treatment of soft tissue sarcoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
BioXcel Therapeutics 555 Long Wharf Drive, 5th Floor New Haven, Connecticut 06511 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-